ÂÜÀòÂÒÂ×

Richard L Wahl

Chair, Scientific & Clinical Advisory Board at Voximetry

Dr. Wahl was among the first to precisely target internal radiation therapy to cancers. He has a successful track record of innovation from the pre-clinical stage to the clinical environment. His significant translational success includes 20 patents, 2 FDA-approved cancer treatments and at least 3 FDA-approved devices. Dr. Wahl is Director of the Mallinckrodt Institute of Radiology at Washington University School of Medicine, Head of the Department of Radiology, and a Professor of Radiation Oncology.

Links